Key Highlights

• Dermal fillers used in cosmetic surgery are injectable chemicals used to restore volume, smooth wrinkles, and enhance facial contours for a more youthful and rejuvenated appearance. Fillers, usually made of hyaluronic acid, collagen or other biocompatible materials, are injected under the surface of the skin to solve various problems such as fine lines, wrinkles, sunken chin, thin lips. Hyaluronic acid fillers, the most popular type, work by attracting and retaining water molecules, plumping the skin and smoothing wrinkles. Collagen fillers derived from natural or synthetic sources can provide similar results by supplementing the body's own collagen. Dermal fillers are versatile and can be used in many areas of the face, including nasolabial folds, marionette lines, and under-eye dimples. The procedure is minimally invasive, performed in a clinical setting, often taking just a short time. The effects are temporary, lasting several months to a couple of years, depending on the type of filler used and the individual's metabolism. Dermal filler treatments are popular in cosmetic surgery due to their non-surgical nature, minimal downtime, and ability to achieve natural-looking results, making them an appealing option for individuals seeking facial rejuvenation without undergoing invasive surgery.

• The market size of the worldwide Dermal Fillers for Cosmetic Surgery Industry surpassed USD XX Billion in 2023, and by 2032, it is projected to reach USD XX billion, boosting at a CAGR of XX%.

• In May 2023, Evolus, Inc., a performance beauty company with a customer-centric strategy committed to delivering ground-breaking products, announced it has entered into a definitive agreement to be the sole U.S. distributor, Symatese, of a line of five distinctive dermal fillers currently in late-stage development. This filler line, EvolysseTM, is extremely competitive and works well with our rapidly expanding aesthetic neurotoxin, Jeuveau. The mainstay of aesthetics are injectables, with neurotoxins and dermal fillers ranking as the top two cosmetic procedures in the United States.

• Increasing interest in plastic surgery is driving the CAGR of the dermal fillers market. The increase in facial surgery performed by both men and women is expected to have a significant impact on the growth of the industry during the forecast period. Recently, people are looking for less medical treatment and less pain to achieve a younger and better appearance. Because plastic surgery can have many risks, it also requires patients to spend more time recovering from surgery. The American Society of Plastic Surgeons reported that approximately $13.2 million in cosmetic procedures were performed in the United States in 2020, of which $3.4 million were collagen fillers. This important information shows that the demand for plastic surgery is increasing. Additionally, the market sees great potential due to the increasing demand for minor surgeries. Companies are developing many new products to meet increasing demand, which is expected to drive growth in the coming years. One of the biggest developments in the global market is that almost everyone wants to learn about noninvasive or minimally invasive treatments. This is especially true for men who resort to plastic surgery to improve their appearance. Many men have found that aging and gravity can affect how they feel about the face. That's why men are turning to facial treatments in the hope of reducing wrinkles. In addition, technological developments in beauty products also accelerate the expansion of the market. The increase in unhealthy habits causes premature aging, causing people to become uncomfortable with their appearance and to the need for filler treatments. In addition, the use of plastic surgery for various purposes such as lip augmentation, chin enlargement and facial rejuvenation increases the demand for dermal filler products.

Scope of the Industry Profile

Key Players

• Merz Pharma (Germany)

• Galderma (Switzerland)

• Sinclair Pharma (U.K.)

• Bioplus Co., Ltd. (South Korea)

• Bioxis pharmaceuticals (France)

• SCULPT Luxury Dermal Fillers LTD (US)

• AbbVie Inc (Allergan Plc.) (US)

• Teoxane Laboratories (Switzerland) 

• Dr. Korman Laboratories Ltd. (Israel)

• Zimmer Aesthetics (Germany)

Segmentation

By End-user

• Specialty & Dermatology Clinics

• Hospitals & Clinics

• Other Users

By Product

• Biodegradable

• Non-Biodegradable

By Material

• Hyaluronic Acid

• Calcium Hydroxylapatite

• Poly-L-lactic Acid

• Collagen

• PMMA (Poly (Methyl Methacrylate))

• Fat Fillers

• Other Materials

By Application

• Scar Treatment

• Wrinkle Correction Treatment

• Lip Enhancement

• Restoration of Volume/Fullness

• Other Application

What to Expect from Industry Profile

1. Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Dermal Fillers for Cosmetic Surgery market in the world.

2. Use the PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the Europe Dermal Fillers for Cosmetic Surgery market.

3. Leading company profiles reveal details of key Dermal Fillers for Cosmetic Surgery market players’ global operations, strategies, financial performance & their recent developments.

4. Add weight to presentations and pitches by understanding the future growth prospects of the Europe Dermal Fillers for Cosmetic Surgery market with forecast for decade by both market share (%) & revenue (USD Million).

Recent Development

• April 2022:Sinclair Pharma reported in April 2022 that Perfectha Lidocaine was granted the European CE mark for its use in wrinkle reduction, face contouring, and density regeneration. This CE accreditation allows Perfectha Lidocaine to launch in the UK and with all significant European markets.

• February 2021:Allergan Aesthetica, along with CollPlant, established a research and worldwide commercial partnership in February 2021 to utilize their plant-based recombinant human collagen (rhCollagen) in conjunction with Allergan's unique technologies to create and commercialize dermal and connective tissue fillers.

• October 2020:Allergan Aesthetics, an AbbVie subsidiary, established a partnership with Luminera, a privately owned aesthetics firm having a product line and pipeline of superficial filler products, in October 2020. According to the terms of the agreement, Allergan Aesthetics acquired Luminera's entire dermal filler portfolio and its research and development pipeline, significantly boosting its top dermal filler offering with its Juvederm filler assortment.

• April 2022:Sinclair Pharma declared that Perfectha Lidocaine, a product used to treat wrinkles, facial contouring, and volume restoration, now carries the European CE mark. With CE marking, Perfectha lidocaine is now available in the UK and all major European markets. Dermal fillers market segmentation

Segment Insights

By End-user

The biodegradable segment is expected to have the highest market share during the forecast period. The higher share of this segment is due to the higher number of products in this segment and the fact that biodegradable products are used more widely than non-biodegradable products. The high level of safety and strong regulatory approval of the product, as well as the existing R&D ideas of large and new operators to create new products in biodegradable media, are also still willing to help develop this segment. For example, in March 2022, Israeli cosmetics company Hallura Ltd. announced that its next-generation hyaluronic acid dermal fillers achieved the best results in multicenter European trials using the proprietary BiOLinkMatrix platform. The safety and effectiveness of dermal fillers have been tested for three indications: lip augmentation, nasolabial fold correction and cheek augmentation. The non-biodegradable segment will have a lower market share in 2022 due to the non-permanence of these products, resulting in lower adoption. Non-biodegradable products do not break down and remain in the body longer than temporary and semi-permanent fillers.

By Material

The calcium hydroxyapatite segment is expected to have the second highest market share in 2022 due to product safety. In addition, the launch of new products by major players in this segment also contributes to the growth of this segment. For example, in April 2022, Allergan Aesthetics launched HArmonyCa with lidocaine. Injectable dermal fillers contain two ingredients: calcium hydroxyapatite (CaHA), which continues to support collagen, and hyaluronic acid, which provides instant lift. The lipofilling segment is expected to expand at a strong CAGR during the forecast period due to the increasing number of lipofilling surgeries in key regions such as North America. The PMMA (polymethylmethacrylate) segment is less commercial due to the non-biodegradability of this product. The Poly-L-lactic acid segment is expected to witness growth due to trends such as product relaunches. Hyaluronic acid (HA) will become an important segment in 2022 due to its status as the gold standard in packaging. Additionally, the introduction of new products in this field has accelerated the growth of this field. The increasing demand for hyaluronic acid products is mainly due to its safety profile and longevity. Furthermore, key companies launching hyaluronic acid products in high-growth countries such as the U.S. and U.K. are expected to drive the segment’s growth during the forecast period.

Regional Insights

The demand for dermal fillers in the German cosmetic industry is driven by many factors. First, Germany's strong economy and high standard of living make beauty procedures, including dermal products, affordable for German people. The country has an aging population; A large portion of the population is seeking solutions to aging problems, increasing the demand for non-invasive treatments such as dermal fillers. Personal culture and health are very important. In Germany, there is a focus on preserving youthful beauty, which increases the demand for beauty treatments. In addition, the influence of media and cultural trends have raised beauty standards, leading people to seek cosmetic procedures, including numbing makeup, to achieve a more beautiful youth. Germany's most advanced medical facilities and talented doctors, create a wonderful environment for plastic surgery. The country has a high-standard medical and cosmetic industry that attracts local and foreign patients seeking skin treatments. In addition, concerns are justified as non-surgical cosmetic treatments are increasingly accepted as solutions to aging problems. As the technology of dermal fillers and procedures continues to improve, German patients tend to prefer this procedure, supporting the growth of the market.